Annals of Emergency Medicine
Volume 52, Issue 6 , Pages 665-676 , December 2008

Transferring Patients With ST-Segment Elevation Myocardial Infarction for Mechanical Reperfusion: A Meta-Regression Analysis of Randomized Trials

  • Giuseppe De Luca, MD, PhD

      Affiliations

    • Division of Cardiology, Maggiore della Carità Hospital, Eastern Piedmont University A. Avogadro, Novara, Italy
    • Corresponding Author InformationAddress for correspondence: Giuseppe De Luca, MD, PhD, Division of Cardiology, Maggiore della Carità Hospital, Eastern Piedmont University A. Avogadro, Novara, Italy; 39-0321-3733141, fax 39-0321-3733407
    • ,
  • Giuseppe Biondi-Zoccai, MD

      Affiliations

    • Division of Cardiology, University of Turin, Turin, Italy
    • ,
  • Paolo Marino, MD

      Affiliations

    • Division of Cardiology, Maggiore della Carità Hospital, Eastern Piedmont University A. Avogadro, Novara, Italy

Received 16 February 2008 ,Revised 21 August 2008 ,Accepted 29 August 2008.

References 

  1. Weaver WD, Simes RJ, Betriu A, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction. JAMA. 1997;278:2093–2098
  2. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361:13–20
  3. Rogers WJ, Canto JG, Barron HV, et al. Treatment and outcome of myocardial infarction in hospitals with and without invasive capability. J Am Coll Cardiol. 2000;35:371–379
  4. King SB, Smith SC, Hirshfeld JW, et al. ACC/AHA/SCAI 2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2008;51:172–209
  5. Dalby M, Bouzamondo A, Lechat P, et al. Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis. Circulation. 2003;108:1809–1814
  6. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials. 1996;17:1–12
  7. Biondi-Zoccai GG, Abbate A, Agostoni P, et al. Stenting versus surgical bypass grafting for coronary artery disease: systematic overview and meta-analysis of randomized trials. Ital Heart J. 2003;4:271–280
  8. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634
  9. Egger M, Smith GD. Bias in location and selection of studies. BMJ. 1998;316:61–66
  10. Morton SC, Adams JL, Suttorp MJ, et al. Meta-regression: What, Why, When, and How?. Rockville, MD: AHRQ; 2004;Technical Review 8. AHRQ Publication 04-0033 http://www.ahrq.gov/downloads/pub/evidence/pdf/metareg/metareg.pdf
  11. Moher D, Cook DJ, Eastwood S, et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement (Quality of Reporting of Meta-analyses). Lancet. 1999;354:1896–1900
  12. Widimsky P, Groch L, Zelizko M, et al. Multicentre randomized trial comparing transport to primary angioplasty versus immediate thrombolysis versus combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory (The PRAGUE Study). Eur Heart J. 2000;21:823–831
  13. Andersen HR, Nielsen TT, Rasmussen K, et al. DANAMI-2 Investigators A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med. 2003;349:733–742
  14. Busk M, Maeng M, Rasmussen K, et al. DANAMI-2 Investigators The Danish multicentre randomized study of fibrinolytic therapy vs. primary angioplasty in acute myocardial infarction (the DANAMI-2 Trial): outcome after 3 years follow-up. Eur Heart J. 2008;29:1259–1266
  15. Widimsky P, Budesinsky T, Vorac D, et al. PRAGUE Study Group Investigators Long distance transport for primary angioplasty versus immediate thrombolysis in acute myocardial infarction. Eur Heart J. 2003;24:94–104
  16. Widimsky P, Bilkova D, Penicka M, et al. PRAGUE Study Group Investigators Long-term outcomes of patients with acute myocardial infarction presenting to hospitals without catheterization laboratory and randomized to immediate thrombolysis or interhospital transport for primary percutaneous coronary intervention (Five years' follow-up of the PRAGUE-2 Trial). Eur Heart J. 2007;28:679–684
  17. Vermeer F, Oude Ophuis AJ, vd Berg EJ, et al. Prospective randomized comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study. Heart. 1999;82:426–431
  18. Grines CL, Westerhausen DR, Grines LL, et al. Air PAMI Study Group A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the Air Primary Angioplasty in Myocardial Infarction study. J Am Coll Cardiol. 2002;39:1713–1719
  19. Bonnefoy E, Lapostolle F, Leizorovicz A, et al. Comparison of Angioplasty and Prehospital Thrombolysis in Acute Myocardial Infarction Study Group Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet. 2002;360:825–829
  20. Dobrzycki S, Mezynski G, Kralisz P, et al. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? (Randomised study. Early results). Kardiol Pol. 2006;64:793–799
  21. Dobrzycki S, Kralisz P, Nowak K, et al. Transfer with GP IIb/IIIa inhibitor tirofiban for primary percutaneous coronary intervention vs. on-site thrombolysis in patients with ST-elevation myocardial infarction (STEMI): a randomized open-label study for patients admitted to community hospitals. Eur Heart J. 2007;28:2438–2448
  22. Dieker HJ, van Horssen EV, Hersbach FM, et al. Transport for abciximab facilitated primary angioplasty versus on-site thrombolysis with a liberal rescue policy: the randomised Holland Infarction Study (HIS). J Thromb Thrombolysis. 2006;22:39–45
  23. Svensson L, Aasa M, Dellborg M, et al. Comparison of very early treatment with either fibrinolysis or percutaneous coronary intervention facilitated with abciximab with respect to ST recovery and infarct-related artery epicardial flow in patients with acute ST-segment elevation myocardial infarction: the Swedish Early Decision (SWEDES) reperfusion trial. Am Heart J. 2006;151:798.e1–798.e7
  24. Di Mario C, Dudek D, Piscione F, et al. CARESS-in-AMI (Combined Abciximab Reteplase Stent Study in Acute Myocardial Infarction) Investigators Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab Reteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial. Lancet. 2008;371:559–568
  25. Canton W. TRANSFER-AMI. http://www.theheart.org/article/851785.doAccessed April 10, 2008
  26. De Luca G, Suryapranata H, Stone GW, et al. Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. JAMA. 2005;293:1759–1765
  27. De Luca G, Gibson M, Bellandi F, et al. Early glycoprotein IIb-IIIa inhibitors in primary angioplasty (EGYPT) cooperation (An individual patient's data meta-analysis). Heart. 2008;Jun 5 [Epub ahead of print]. doi:10.1136/hrt.2008.141648
  28. De Luca G, Suryapranata H, Ottervanger JP, et al. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation. 2004;109:1223–1225
  29. De Luca G, Suryapranata H, Zijlstra F, et al. ZWOLLE Myocardial Infarction Study Group Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol. 2003;42:991–997
  30. Bednar F, Widimsky P, Krupicka J, et al. PRAGUE Study Group Investigators Interhospital transport for primary angioplasty improves the long-term outcome of acute myocardial infarction compared with immediate thrombolysis in the nearest hospital (one-year follow-up of the PRAGUE-1 study). Can J Cardiol. 2003;19:1133–1137
  31. Zijlstra F, Beukema WP, van't Hof AW, et al. Randomized comparison of primary coronary angioplasty with thrombolytic therapy in low risk patients with acute myocardial infarction. J Am Coll Cardiol. 1997;29:908–912
  32. Tarantini G, Razzolini R, Ramondo A, et al. Explanation for the survival benefit of primary angioplasty over thrombolytic therapy in patients with ST-segment elevation acute myocardial infarction. Am J Cardiol. 2005;96:1503–1505
  33. Keeley EC, Boura JA, Grines CL. Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials. Lancet. 2006;367:579–588
  34. Brodie BR, Stuckey TD, Wall TC, et al. Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 1998;32:1312–1319
  35. De Luca G, Ernst N, Zijlstra F, et al. Preprocedural TIMI flow and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol. 2004;43:1363–1367
  36. Gersh BJ, Stone GW, White HD, et al. Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future?. JAMA. 2005;293:979–986
  37. Stone GW, Dixon SR, Grines CL, et al. Predictors of infarct size after primary coronary angioplasty in acute myocardial infarction from pooled analysis from four contemporary trials. Am J Cardiol. 2007;100:1370–1375
  38. Steg PG, Bonnefoy E, Chabaud S, et al. Comparison of Angioplasty and Prehospital Thrombolysis in Acute Myocardial Infarction (CAPTIM) Investigators Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial. Circulation. 2003;108:2851–2856
  39. Pinto DS, Kirtane AJ, Nallamothu BK, et al. Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy. Circulation. 2006;114:2019–2025

 Supervising editors: Deborah B. Diercks, MD; Judd E. Hollander, MD

 Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article that might create any potential conflict of interest. The authors have stated that no such relationships exist. See the Manuscript Submission Agreement in this issue for examples of specific conflicts covered by this statement.

 Earn CME Credit: Continuing Medical Education for this article is available at: www.ACEP-EMedHome.com.

 Reprints not available from the authors.

PII: S0196-0644(08)01720-4

doi: 10.1016/j.annemergmed.2008.08.033

Annals of Emergency Medicine
Volume 52, Issue 6 , Pages 665-676 , December 2008

Article Tools

* Image Usage & Resolution